文献速递心力衰竭与心肌病瓣膜病与结构性心脏病

药物、介入与外科干预对慢性心衰中成比例与不成比例功能性二尖瓣反流的相反效应

Contrasting Effects of Pharmacological, Procedural, and Surgical Interventions on Proportionate and Disproportionate Functional Mitral Regurgitation in Chronic Heart Failure.
PubMed 文献 · Circulation · 2019-05-01

该综述提出慢性心衰合并射血分数降低患者功能性二尖瓣反流(MR)存在两条通路:左室重构导致瓣环扩张与瓣叶牵拉时,有效反流口面积与左室舒张末容积呈线性关系,为成比例MR;心室不同步导致乳头肌收缩不均时,反流程度超出左室容积预测,为不成比例MR。成比例MR对逆转左室重构的治疗反应良好,不成比例MR对针对瓣叶或支撑结构的治疗反应良好,该框架可指导临床选择最合适治疗。

要点

  • 成比例MR对神经激素拮抗剂和左室辅助装置等逆转重构治疗反应良好。
  • 不成比例MR对心脏再同步化或经导管二尖瓣修复等针对瓣叶治疗反应良好。
  • 仅针对瓣叶的干预可能对成比例MR获益有限,仅缩小左室腔的干预可能对不成比例MR获益有限。

核心结论

  • 功能性MR可分为成比例与不成比例两类,其治疗反应方向相反,应据此选择个体化治疗。

研究设计与样本

  • 综述性概念框架,基于慢性心衰伴射血分数降低患者的功能性MR病理生理机制进行阐述。

主要发现

  • 成比例MR中左室舒张末容积与有效反流口面积呈线性关系,由左室重构致瓣环扩张和瓣叶牵拉引起。
  • 不成比例MR中反流程度大于左室容积预测值,由心室不同步致乳头肌收缩不均引起。
  • 成比例MR对逆转左室重构的治疗反应良好,不成比例MR对针对瓣叶或支撑结构的治疗反应良好。

临床怎么用

  • 临床评估功能性MR时应区分成比例与不成比例,以指导选择逆转重构治疗或针对瓣叶/支撑结构的治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Two distinct pathways can lead to functional mitral regurgitation (MR) in patients with chronic heart failure and a reduced ejection fraction. When remodeling and enlargement of the left ventricle (LV) cause annular dilatation and tethering of the mitral valve leaflets, there is a linear relationship between LV end-diastolic volume and the effective regurgitant orifice area of the mitral valve. These patients, designated as having proportionate MR, respond favorably to treatments that lead to reversal of LV remodeling and a decrease in LV volumes (eg, neurohormonal antagonists and LV assist devices), but they may not benefit from interventions that are directed only at the mitral valve leaflets (eg, transcatheter mitral valve repair). In contrast, when ventricular dyssynchrony causes functional MR attributable to unequal contraction of the papillary muscles, the magnitude of regurgitation is greater than that predicted by LV volumes. These patients, designated as having severe but disproportionate MR, respond favorably to treatments that are directed to the mitral valve leaflets or their supporting structures (eg, cardiac resynchronization or transcatheter mitral valve repair), but they may derive little benefit from interventions that act only to reduce LV cavity size (eg, pharmacological treatments). This novel conceptual framework reflects the important interplay between LV geometry and mitral valve function in determining the clinical presentation of patients, and it allows characterization of the determinants of functional MR to guide the most appropriate therapy in the clinical setting.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Packer M, Grayburn PA. Contrasting Effects of Pharmacological, Procedural, and Surgical Interventions on Proportionate and Disproportionate Functional Mitral Regurgitation in Chronic Heart Failure. Circulation. 2019. PMID: 31070944. doi:10.1161/CIRCULATIONAHA.119.039612

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。